Answers are grounded in this paper and cite their sources.
Cardiac glycosides have been used in the treatment of cardiac failure for more than 200 years. Digitalis and its analogues have been shown to increase myocardial contractility and to decrease left ventricular end‐diastolic pressure and volume, while causing no essential change in aortic pressure and a variable decrease in heart rate. 1–2 However, several reports 3–8 have questioned the use of digitalis in patients with ventricular dysfunction, particularly in view of the newer modes of therapy. The aim of this study was to define the effects of rapid digitalization on left and right ventricular function in patients with chronic congestive heart failure, using radionuclide methods.
No takes yet. Share an insight, caveat, or question.
Rotenberg et al. (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: